Wentworth Home Care & Hospice, An Amedisys Partner Medicare Approved Location: 9 Andrews Road, Somersworth, New Hampshire 03878 Phone: (603) 740-9285 |
News Archive
Demonstrating the value of standards-based health information technologies, MedQuist Inc., a leading provider of technology-enabled clinical documentation services, is participating as an Implementer in the HIMSS10 Interoperability Showcase at booth #233 in Hall C of the Georgia World Congress Center in Atlanta, Georgia. The Showcase is part of the 2010 Annual Healthcare Information and Management Systems Society Conference & Exhibition being held from March 1-4.
Resveratrol, a compound present in grapes and red wine, reduces the number of fat cells and may one day be used to treat or prevent obesity, according to a new study. The results will be presented at The Endocrine Society's 90th Annual Meeting in San Francisco.
Ben Armstrong and Luis Arbulu of Hattery Labs, a collaborative design firm, write in this post in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog about how they are beginning "to explore how games might improve sanitation practices."
We've all experienced a "gut feeling" - when we know deep down inside that something is true. That phenomenon and others (like "butterflies in the stomach") aptly describe what scientists have now demonstrated: that the gut and the brain are more closely connected than we once thought, and in fact the health of one can affect the other.
Iverson Genetic Diagnostics today announced the company has received approval from CMS to conduct a WARFARIN Clinical Study. The two-year (2) study will assess the impact of genetic information in calculating doses and the changes in the rate of adverse events when initiating Warfarin drug therapy. These changes will be compared against doses initiated without genetic data. The randomized and blinded, multi-center study will involve more than 7000 participants at over 50 sites nationwide.
› Verified 8 days ago